98%
921
2 minutes
20
Background: Immunisation is an essential and cost-effective way of preventing infectious diseases. The emergence of new diseases, including COVID-19, along with advancements in malaria vaccines, has potentially led to an increase in vaccinations, particularly among children under 5 years old in Africa. However, concerns about vaccine safety have led to a decline in trust and greater vaccine hesitancy, as evidenced by the low uptake of newly introduced vaccines like the pneumococcal vaccine-13 in Ghana.Adverse events following immunisation (AEFIs) may range from mild to severe and are of concern because vaccines are generally given to healthy people. To monitor vaccine safety, it is important that those who experience adverse events report to the nearest health facility, but compliance is low in Ghana. This study explored the knowledge and experiences of mothers in northern Ghana regarding vaccine safety and adverse event reporting procedures.
Methods: This cross-sectional exploratory study used a qualitative research design that involved 10 focus group discussions (FGDs) with mothers from 5 administrative regions in resource-limited Northern Ghana. Participants for the FGDs were selected through a purposive sampling method at childhood vaccination clinics. All the interviews were recorded, transcribed and coded into themes using QSR NVivo V.12 software to aid thematic content analysis.
Results: The results revealed that mothers understood the need for vaccinations, although some were unaware of the diseases that the vaccines protect against. Even though most mothers knew about the benefits of vaccinations, many expressed concerns about the pain and discomfort their children experienced during the process. Furthermore, they noted that the absence of responses from health workers following the reporting of AEFIs, the belief that adverse events are commonplace, and previous vaccination experiences all influenced AEFI reporting. The fear of serious adverse events such as paralysis, coupled with insufficient explanation of the benefits, may dissuade parents from allowing their children to receive vaccinations. The findings also revealed that mothers were not adequately informed about vaccines and the need for them to report adverse events.
Conclusions: Many individuals regard vaccines as an essential public health intervention for preventing diseases and their related complications. Public health agencies and healthcare providers ought to address concerns about vaccine adverse events by providing thorough education for mothers about vaccines and AEFI reporting.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12336584 | PMC |
http://dx.doi.org/10.1136/bmjph-2024-001761 | DOI Listing |
Circulation
September 2025
Division of Cardiology, Columbia University Irving Medical Center, New York, NY (S.A.P.).
Background: Limited treatment options exist for infrapopliteal disease in patients with chronic limb-threatening ischemia (CLTI), a condition associated with a high risk of limb loss. Interventional management of diseased infrapopliteal vessels with percutaneous transluminal angioplasty (PTA) is associated with high rates of restenosis and reintervention. In the LIFE-BTK trial, the drug-eluting resorbable scaffold (DRS) demonstrated superior 12-month efficacy compared with PTA in a selected CLTI population with predominantly noncomplex, mildly to moderately calcified lesions.
View Article and Find Full Text PDFRetin Cases Brief Rep
October 2024
Eye Clinic, Humanitas-Gradenigo Hospital, Torino, Italy.
Purpose: To study the efficacy and safety of pro re nata regimen of brolucizumab, without loading dose, in treatment-naive patients with neovascular age-related macular degeneration (nAMD).
Case Series: Retrospective, observational study. We included all consecutive patients diagnosed with treatment- naïve nAMD undergoing Brolucizumab in Humanitas eye clinic, Turin, Italy between April 2022 and May 2023.
Cutan Ocul Toxicol
September 2025
Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER) Guwahati, Kamrup, Assam, India.
Objective: This study aimed to assess the potential risk of Bullous pemphigoid (BP) associated with antidiabetic agents, antimicrobials, diuretics, immune checkpoint inhibitors, and biological agents.
Research Design And Methods: A retrospective pharmacovigilance data analysis was conducted using the FDA Adverse Event Reporting System (FAERS) between Q1/2004 and Q3/2024. Disproportionality analyses, viz.
Eur J Case Rep Intern Med
July 2025
Intensive care unit, Clinical Hospital Sveti Duh, Zagreb, Croatia.
Background: Tacrolimus is a commonly used immunosuppressant with well-defined side effects, including hypertriglyceridemia and hyperglycaemia. However, acute pancreatitis is still not widely recognized as an adverse event related to tacrolimus.
Case Presentation: A 60-year-old male was admitted to the intensive care unit with symptoms and signs of acute pancreatitis.
Int J Gen Med
September 2025
Department of Pediatric, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, 130000, People's Republic of China.
Background: Mycoplasma pneumoniae pneumonia (MPP) is a common respiratory infection in children, current treatments are limited by resistance and side effects. This study aims to evaluate the clinical efficacy and safety of combining Qingke Mixture with azithromycin for treating MPP in children.
Methods: This prospective, randomized, double-blind, controlled trial included 92 children diagnosed with MPP.